DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ: DMII · FINANCIAL SERVICES · SHELL COMPANIES
$10.02
+0.10% today
Updated 2026-04-30
Market cap
$637.64M
P/E ratio
66.73
P/S ratio
—
EPS (TTM)
$0.15
Dividend yield
—
52W range
$10 – $10
Volume
0.1M
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 2
Last 2 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.1%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-0.1%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $0.07 | — | $9.91 | $9.90 | -0.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $0.07 | — | — | — |
| 2025-09-30 | $0.00 | $0.00 | — | — | — |
Frequently asked questions
Has Drugs Made In America Acquisition II Corp. Ordinary Shares beaten earnings estimates?
Drugs Made In America Acquisition II Corp. Ordinary Shares has beaten Wall Street EPS estimates in 1 of its last 2 quarterly reports.
How does DMII stock react to earnings?
DMII stock has moved an average of -0.1% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.